Now Virtual!
Digital Access & LIVE Q&A
January 30, 2021

IBD School: 8.50 CME Credits, 8.50 MOC Points

Course Description:

In order to maximize effective online clinical education, ACG will be offering IBD School as a flexible combination of on-demand education supported by engaging LIVE Q&A and cases with expert faculty. With ACG’s NEW VIRTUAL IBD SCHOOL, you’ll receive on-demand access to over 5.5 hours of recorded lectures delivered by world-class faculty. Each of the 13 lectures will help you improve clinical judgment and address the art and science of IBD management.

Advance Online Viewing Available: Videos will be available for viewing starting on Friday, January 15th. Watch the videos on your own time and have access to them for up to one year following the course.

Exclusive Live Q&A If You Register Now! Those who register by Friday, January 29th will receive exclusive access to three LIVE webcast sessions on January 30th plus a bonus satellite symposium!

Live Q&A Sessions: IBD experts Dr. Sunanda Kane and Dr. David Rubin will host two LIVE Q&A sessions with the IBD School faculty on January 30th from 2:00 pm – 2:45 pm and from 4:45 pm – 5:30 pm (Eastern Time). NEW for this course, we have also added a 90 minute case-based session with the faculty! This session will take place from 3:00 pm – 4:30 pm (Eastern Time). Attendees will have the opportunity to submit questions in advance and during the live broadcasts. As an added resource, the recordings of the Q&A sessions will be made available to registrants following the sessions.

Agenda and LIVE Q&A Schedule

IBD School Course Directors:

PhotoSunanda V. Kane, MD, MSPH, FACG
PhotoDavid T. Rubin, MD, FACG

Registration Fees: IBD School

Registration Fee Registration Category
$99 ACG Physician Member / Fellow
$99 ACG Candidate/Trainee/Resident Member
$99 ACG Advanced Practice Provider / Associate Member
$149 Non-Member Physicians / PharmD / PhD / Guest
$149 Non-Member Trainee / GI Fellow / Resident
$149 Non-Member NP / PA / Allied Health (RN, LPN)

Register Now

Satellite Symposium*:

Saturday, January 30th – 5:45 pm (EDT)

Breakthroughs with NASH Management: What Do Gastroenterologists and Hepatologists Need to Know?
Stephen A. Harrison, MD; Zobair M. Younossi, MD, MPH, FACP, FACG, AGAF

Program Overview
Non-alcoholic steatohepatitis (NASH), an advanced form of non-alcoholic fatty liver disease (NAFLD), is a severe liver disorder with a rapidly progressive course that can lead to liver fibrosis, cirrhosis, and hepatocellular carcinoma. In order to prevent irreversible liver damage, patients with NASH should receive immediate treatment. However, distinguishing NASH from other liver disorders and identifying high-risk patients remain challenging, and there are limited treatment options once a patient is diagnosed. While there are no approved medical therapies for NASH, multiple investigational agents have shown promise in late-stage trials and are expected to be available for NASH treatment soon.

This activity, Breakthroughs with NASH Management: What Do Gastroenterologists and Hepatologists Need to Know? will provide clinicians with the most current guidance on NASH diagnostic strategies. Clinician learners will also receive information on the efficacy, safety, and potential use of novel agents in late-stage clinical investigation for the treatment of patients with NASH.

For more information, please visit our website or click here to register.

*These events are neither sponsored by nor endorsed by ACG.

For more information on supporting this conference through a virtual exhibitor presence, please email

Accreditation / CME / MOC:

The American College of Gastroenterology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

ACG’s Virtual IBD School: The American College of Gastroenterology designates this other activity (blended learning) for a maximum of 8.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 8.50 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

The American College of Gastroenterology acknowledges educational grant support for this IBD School program from:

  • Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC.
  • Medtronic
  • Olympus